Expand EYPT Menu
EYPT MENU

EYPT Stock Summary and Trading Ideas (Eyepoint Pharmaceuticals | NASDAQ:EYPT)

Charts for Today's Stock Price and Implied Volatility in Eyepoint Pharmaceuticals

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for EYPT by Theoretical Edge and Win Rates

Sentiment

News

Trading Statistics

Key Ratios

Eyepoint Pharmaceuticals (EYPT) Frequently Asked Questions

What does Eyepoint Pharmaceuticals do?

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

What symbol and exchange does Eyepoint Pharmaceuticals shares trade?

Eyepoint Pharmaceuticals trades on the NASDAQ stock market under the symbol EYPT.

What is Eyepoint Pharmaceuticals stock price doing today?

As of February 11, 2025, EYPT stock price declined to $6.01 with 235,477 million shares trading.

What is Eyepoint Pharmaceuticals's Beta?

EYPT has a beta of 1.29, meaning it tends to be more sensitive to market movements. EYPT has a correlation of 0.03 to the broad based SPY ETF.

How much is Eyepoint Pharmaceuticals worth?

EYPT has a market cap of $410.19 million. This is considered a Small Cap stock.

How much money does Eyepoint Pharmaceuticals make?

Last quarter Eyepoint Pharmaceuticals reported $11 million in Revenue and -$.54 earnings per share. This beat revenue expectation by $594,000 and exceeded earnings estimates by $.01.

What is the highest and lowest price Eyepoint Pharmaceuticals traded in the last 3 year period?

In the last 3 years, EYPT traded as high as $30.99 and as low as $2.19.

What are the top ETFs holding Eyepoint Pharmaceuticals?

The top ETF exchange traded funds that EYPT belongs to (by Net Assets): VTI, IWM, VXF, VTWO, IWN.

Is Eyepoint Pharmaceuticals (EYPT) a good investment?

EYPT has underperformed the market in the last year with a price return of -79.1% while the SPY ETF gained +22.1%. EYPT has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -48.3% and -25.1%, respectively, while the SPY returned +1.4% and +0.9%, respectively.

What are the support and resistance levels for Eyepoint Pharmaceuticals (EYPT)?

EYPT support price is $5.87 and resistance is $6.68 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that EYPT shares will trade within this expected range on the day.